baber/WOPTO huggingface dataset:
Patent DK-1024233-T3 (DK)
Inventor: DIETER HANS-PETER
IPC: E04D3/08
Filed: 2000-01-26
Granted: 2001-07-30
Abstract: A system for fitting roof panels has a two part frame with the bottom frame (3) supported on the roof mountings and with a separate top frame (1) which clips into the bottom frame and clamps onto the edges of adjoining panels. The panels are fitted by first having the frame sections in an initial position for a loose grip. This enables the operator to slide the panels into position. The two parts of the frame are pulled together by threaded fasteners tightened from the underside of the frames, ie. under the roof. The frames are fitted with profiled edge strips which provide a watertight seal onto the panels.
Patent DK-1204420-T3 (DK)
Inventor: COLACO CAMILO ANTHONY LEO SELW
IPC: A61P31/10
Filed: 2000-08-18
Granted: 2007-09-17
Abstract: The present invention relates to methods for using prokaryotic cells which have been modified or induced to synthesize trehalose as vaccines and to vaccine compositions obtained thereby.
Patent DK-1222076-T3 (DK)
Inventor: KERMELK WERNER
IPC: B60B21/02
Filed: 2000-09-06
Granted: 2005-12-12
Abstract: The invention relates to a vehicle wheel for the front axle of a goods vehicle, which is preferably applicable to wide base tyres and comprises a nominal rim width greater than 11.75''. The vehicle wheel further comprises a wheel disc (1) and a steeply shouldered rim (11), in which a rim drop centre (14) comprising a drop centre base (15) and drop centre tapers (16, 17) is arranged. The base (15) of the drop centre (14) extends on both sides of the rim centre (F) in an essentially straight line and the outer taper (17) and inner taper (16) are respectively connected to the rim shoulders. The wheel disc (1) is welded to the base (15) of the drop centre (14). The inventive embodiment results in vehicle wheels (10) with a broad drop centre that preferably takes up 65 %-75 % of the width of the rim (11). Production of the inventive wheels requires less material and there are practically no undercuts where mud, stones and similar can collect.
Patent DK-1234908-T3 (DK)
Inventor: GRANDPIERRE CYRIL MARC MICHEL
IPC: D06F65/02
Filed: 2001-02-20
Granted: 2005-06-13
Abstract: Dryer-ironer with heated ironing cup and heat-carrying fluid.In a dryer-ironer with heated cup (10), the cup is built so as to define a closed chamber (26) containing a heat carrying fluid between two parallel walls (18, 22). The fluid is set into motion through a stirring system integrated with the cup so as to provide the establishment of a uniform temperature along its entire length.
Patent DK-1328585-T3 (DK)
Inventor: MALOT MICHEL
IPC: C08K9/04
Filed: 2001-10-23
Granted: 2006-04-24
Abstract: The invention concerns a method for making cold-process bituminous mixes, using a bitumen-type emulsion in aqueous phase and aggregates. It consists of treating said aggregates with an agent providing hydrophobicity, prior to mixing said emulsion with said aggregates.
Patent DK-1231412-T3 (DK)
Inventor: HANSEN HENRY
IPC: F16H25/20
Filed: 2002-02-08
Granted: 2005-10-17
Abstract: In a linear actuator of the type where an actuation rod (6) is driven by a reversible electric motor via a spindle/nut (4, 5), a jamming protection is provided, based on the spindle (4) being arranged axially movably so that a gear wheel (10) on the end thereof is disengaged from the transmission upon movement in one direction. If the actuation rod (6) is blocked in its movement, the connection between the spindle (4) and the transmission will be interrupted automatically. A spring force (13) keeps the spindle (4) engaged with the transmission in normal operation. The jamming protection is simple and operates reliably, has a minimum mounting length and also ensures that the actuation rod cannot be pulled out of engagement with the spindle nut. <IMAGE>
Patent DK-1433266-T3 (DK)
Inventor: BULTAN AYKUT
IPC: H04L7/02
Filed: 2002-04-15
Granted: 2006-04-03
Abstract: A user equipment, UE, comprising a receiver for receiving a communication signal from at least one base station; and a delay-locked code tracking loop, DCTL, for estimating and tracking a channel delay of said received communication signal, the DCTL comprising: a reference code generator (16) for generating a reference code signal; an interpolator (11) for generating a punctual output signal, an early output signal and a late output signal; a first timed signal correlator (12a) for correlating said early output signal with said reference code signal to generate a first correlated signal; a second timed signal correlator (12b) for correlating said late output signal with said reference code signal to generate a second correlated signal; a third timed signal correlator for correlating said punctual output signal with said reference code signal to generate a third correlated signal; an adder for combining the first and second correlated signals to generate a first error signal; an automatic power normalization, APN, loop (20) for generating a second error signal based on said third correlated signal; and a normalization circuit for normalizing said first error signal by using said second error signal to generate a third error signal used for controlling the generation of the punctual output signal by the interpolator.
Patent DK-1443967-T3 (DK)
Inventor: CHEN YING-NAN PAN
IPC: A61K31/343
Filed: 2002-11-05
Granted: 2007-04-16
Abstract: The invention relates to a combination which comprises (a) a cyclooxygenase-2 inhibitor ("COX-2 inhibitor") and (b) a histone deacetylase inhibitor ("HDAI") for simultaneous, concurrent, separate or sequential use, especially for use in the treatment of pre-malignant colon lesions or a colon cancer or other malignancies in a mammal, particularly a human. The invention also relates to pharmaceutical compositions comprising such a combination and to a method of treating pre-malignant colon lesions (e.g. polyps) and colon cancer, as well as other malignancies, in a mammal, particularly a human, with such a combination. The present invention further also relates to a commercial package or product comprising such a combination.
Patent DK-1430773-T3 (DK)
Inventor: MUGFORD ROGER ARTHUR
IPC: A01K15/02
Filed: 2003-12-18
Granted: 2010-06-07
Abstract: A hand held training device (1) capable of producing discreet clicks when operated by a user, having a means (13, 21) by which the user can vary the volume and/or tone of the clicks produced. <IMAGE>
Patent DK-1498129-T3 (DK)
Inventor: ALEMANY BONASTRE RAMON
IPC: A61K35/761
Filed: 2003-03-25
Granted: 2006-04-03
Abstract: This invention refers to the use of an adenovirus for cancer treatment, being this adenovirus defective in its virus-associated (VA) RNAs. Said adenovirus has a mutation in the VAI or VAII gene sequence or both. This adenovirus may also have mutations in the sequences controlling expression of the VA RNAs.
Patent DK-1507858-T3 (DK)
Inventor: BECKHOVEN VAN RUDOLF FRANCISCU
IPC: A23J1/00
Filed: 2003-05-28
Granted: 2009-02-02
Abstract: The invention disclose a method for purifying microbial protease, comprising:(i) providing an aqueous liquid sample containing a microbial protease, and a separation medium comprising a base matrix and a plurality of attached ligands that are capable of binding to microbial protease;(ii) contacting separation medium with the sample under conditions permitting binding of microbial protease to the separation medium; and (iii) desorbing microbial protease from the separation medium, wherein the base matrix is hydrophilic and the plurality of ligands are hydrocarbon groups in which all carbon atoms are sp3-hybridised.
Patent DK-1525219-T3 (DK)
Inventor: STEINESS EVA
IPC: A61K38/28
Filed: 2003-07-02
Granted: 2009-09-07
Abstract: The present invention relates to use of GLP-1 or a related molecule having GLP-effect for the manufacture of a medicament for preventing or treating diabetes in a mammal. The amount and timing of administration of said medicament are subsequently reduced to produce a "drug holiday". Practice of the invention achieves effective therapy without continuous drug exposure and without continuous presence of therapeutic levels of the drug. The invention also discloses a method of treating diabetes and related disorders in a mammal by administering glucagon like peptide (GLP-1) or a related molecule having GLP-1 like effect and thereby providing a therapeutically effective amount of endogenous insulin.
Patent DK-1550474-T3 (DK)
Inventor: NISHIKAWA HISAO
IPC: A61M5/158
Filed: 2003-07-10
Granted: 2009-06-08
Abstract: An injection needle has a puncture section having a small diameter that does not give a patient pain, injury, etc. and, moreover, does not make a patient feel fear and anxiety, a base end section with a large diameter to achieve a required flow rate and strength, and a tapered section connecting the puncture section and the base end section. The injection needle and a liquid introducing instrument can eliminate pain caused by a tapered section, and excellent puncture can be made with the needle and the instrument. An injection needle (1) has a puncture section (2) provided with a needle point that can be punctured into a living body, a base end section (3) having an outer and an inner diameter larger than the puncture section (2), a tapered section (4) connecting the puncture section (2) and the base end section (3). The tapered section (4) has smaller puncture resistance than the puncture section (2), or specifically, taper angle (A) is equal to or less than 2 degrees. <IMAGE>
Patent DK-1567298-T3 (DK)
Inventor: ZANDER HAAKAN
IPC: E04F15/02
Filed: 2003-11-14
Granted: 2012-05-14
Abstract: A process for the manufacturing of a decorative laminate, having an upper decorative and abrasion resistant thermosetting laminate layer and a carrying core. The upper side of the core has the abrasion resistant thermosetting laminate while the lower side of the core has a balance layer. This balance layer prevents warping of the decorative laminate while at the same time providing acoustic dampening. The balance layer includes a layer of a polymer. The balance layer and the thermosetting laminate are joined with the core by pressing. The carrying core further is provided with a dampening foil of an elastomer arranged between the upper side of the core and the abrasion resistant thermosetting laminate. The elastomer and thermosetting laminate are joined with each other and with the core by pressing. The achieved laminate is then cut into panels and provided with edges intended for joining.
Patent DK-1559314-T3 (DK)
Inventor: FRANSEN RENATUS IGNATIUS JOSEP
IPC: A01J7/02
Filed: 2004-12-17
Granted: 2007-06-11
Abstract: A device for cleaning, during a cleaning period, a milking installation for milking an animal. The milking installation comprises a milk line (1) for discharging milk to a milk tank (2). A milk filter is included in the milk line. The device is provided with a rinsing water device for rinsing, during a rinsing period, the milk line and the milk filter with rinsing water, the cleaning period comprising the rinsing period. The milk filter comprises a first (3) and a second milk filter element (4) arranged parallel to each other. A switchable valve element (5) is included in the milk line and is capable of being put into a first position for connecting the milk line to the first milk filter element (3) and into a second position for connecting the milk line to the second milk filter element (4). The device is provided with a control unit for operating during at least one cleaning period, and preferably during each cleaning period, the switchable valve element for connecting the milk line to the other milk filter element. <IMAGE>
Patent DK-1561574-T3 (DK)
Inventor: TECK SANG SIAW
IPC: C08L23/10
Filed: 2004-02-06
Granted: 2008-12-08
Abstract: A binder comprising 5-50 wt% of a mixture (A) and 50-95 wt% polypropylene (PP) (co)polymer, in which (A) contains 5-100 wt% of an unsaturated acid-grafted mixture of metallocene polyethylene and LLDPE or PP (co)polymer and 95-0 wt% polyethylene homo- or co-polymer or elastomer. A binder comprising (A) 5-50 wt% of a mixture containing (a1) 5-100 wt% of a mixture of copolymers comprising (C1) 90-20 wt% metallocene polyethylene with a density of 0.865-0.915 and (C2) 10-80 wt% non-metallocene LLDPE or polypropylene homo- or co-polymer, the mixture (C1 + C2) being co-grafted with an unsaturated carboxylic acid monomer or a functional derivative thereof and (a2) 95-0 wt% polyethylene (homopolymer, copolymer or elastomer), such that (A) has a grafting monomer content of 30-100000 ppm and an MFI (190/2.16) of 0.1-30 g/10 min, and (B) 50-95 wt% polypropylene homo- or co-polymer. Independent claims are also included for: (1) a multilayer structure with a layer (2) of binder as above; (2) film with a multilayer structure as above; (3) film comprising a printed layer of biaxially-oriented polypropylene (BOPP) or polyethylene terephthalate (BOPET) and an adhesively-bonded metallised multilayer film as above, in which the film may or may not be biaxially-oriented and the metal layer (1) is directly bonded to the BOPP or BOPET by the adhesive; and (4) objects made with multi-layer structures or film as above.
Patent DK-1457196-T3 (DK)
Inventor: LE BOURHIS FRANCOIS
IPC: A61K8/31
Filed: 2004-03-03
Granted: 2007-09-24
Abstract: Aerosol devices are claimed containing: (A) a cosmetic composition comprising at least one polyurethane (I) in a medium containing water and organic solvent(s); and (B) a propellant consisting of dimethyl ether (DME) and 3-5C hydrocarbon(s) (II).
Patent DK-1594964-T3 (DK)
Inventor: JOCKERS RALF
IPC: C12Q1/68
Filed: 2004-02-09
Granted: 2012-07-23
Abstract: Oligonucleotides (ON), optionally modified and comprising 8-50 nucleotides (nt), that hybridize specifically to a 648 base pair (bp) sequence (1), given in the specification, and that inhibit expression of the leptin receptor related protein (OB-RGRP), are new. Independent claims are also included for the following: (1) interfering RNA (iRNA) of 15-25 nt that hybridize specifically with a 1114 bp sequence (21), reproduced, and inhibit expression of OB-RGRP; (2) vector that expresses ON or iRNA; (3) cell containing the vector of (2); (4) pharmaceutical composition containing ON, iRNA, the vector of (2) or the cell of (3); (5) fusion protein (FP) comprising a sequence with at least 65% identify with sequences (4) or (16), both of 131 amino acids (aa), or a substantial part of them, and a protein that is a donor or acceptor of energy, or a substantial part of it; (6) nucleic acid (I) that encodes FP; (7) nucleic acid with at least 65% identity with (I) or that hybridizes to it under stringent conditions; (8) cells that contain (I), or express FP, also their fragments, lysates and membranes; (9) methods for determining modified interaction between (4) or (13), or their homologs with at least 65% identity, and the leptin receptor; and (10) method for screening or detecting compounds that can be used to prevent or treat leptin-related disorders. ACTIVITY : Osteopathic; Anorectic; Antidiabetic; Cytostatic; Antiinflammatory; Immunomodulatory; Anabolic; Endocrine-Gen.; Antianemic; Antiangiogenic. MECHANISM OF ACTION : Inhibiting expression of OB-RGRP. HeLa cells were transformed with a vector that expressed the leptin receptor (OB-R) and a reporter gene (STAT3) and with an antisense agent, AS14, directed specifically against the OB-R related protein 3'-(triethylene glycol)-TGtAcAcGtGtAcGCcGtAa (AS14) (upper case indicates phosphorothioate; the five bases at each end are 2'-O-methylated). In absence of AS14, STAT3 activity was increased by 50% in presence of leptin, but in presence of AS14, leptin almost doubled STAT3 activity.
Patent DK-1593305-T3 (DK)
Inventor: SIGMANS MARINUS ANTONIUS J M
IPC: A01K63/04
Filed: 2005-05-03
Granted: 2010-03-01
Abstract: The invention provides a device for the metered passage of a liquid, comprising a container for the liquid, which is provided with an inlet and an outlet for supplying liquid to and discharging liquid from the container, respectively, and with a bottom and upright side walls joining said bottom. The device furthermore comprises means for regulating the extent to which liquid is supplied to the container via the inlet in dependence on the amount of liquid that is present in the container. The metering means comprise a floating element which floats on the liquid in the container and which is rigidly connected to an overflow edge that can move up and down together with the floating element between a lowermost position and an uppermost position, over which overflow edge the liquid flows into the container at the location of the inlet. The overflow edge forms part of at least one side wall of the container.
Patent DK-1591445-T3 (DK)
Inventor: GREENWOOD ALAN
IPC: C07D457/06
Filed: 2005-04-29
Granted: 2008-08-11
Abstract: The present invention discloses a method for preparing cabergoline form I by combining cabergoline and a solvent comprising ethylbenzene to form a solvate and obtaining form I from the solvate. Also disclosed in a method for preparing cabergoline form I by combining cabergoline and a first solvent to form a solution and additionally including a second solvent to the solution, followed by crystallization to form cabergoline form I. Further disclosed is a solvate form of cabergoline comprising cabergoline and ethylbenzene and, optionally, n-heptane.
Patent DK-1842117-T3 (DK)
Inventor: SPIGAI ALBERTO
IPC: A63B55/60
Filed: 2005-01-20
Granted: 2010-08-09
Abstract: A cart for transporting objects and various goods, in particular on golf courses, comprising at least one electric traction motor fed by at least one set of accumulators installed on board the cart, a series of ultrasonic sensors apt to detect the signals coming from an external source of signals, and a microcomputer control unit which interfaces with said sensors and with an electronic speed regulator of said at least one electric motor, is automatically guided to maintain a pre-determined position set in respect of the position of said extemal source of reference signals. Special algorithms are implemented in the microcomputer control unit of the cart in order to exactly determine the mutual position cart / source and to avoid interferences with similar carts operating in the same area.
Patent DK-1902149-T3 (DK)
Inventor: HOWELLS ANDREW DAVID
IPC: C22C21/02
Filed: 2006-06-29
Granted: 2009-03-30
Abstract: An aluminium alloy product having a gauge below 200 μm and a composition, in weight %, of Fe 1.0-1.8, Si 0.3-0.8, Mn up to 0.25, other elements less than or equal to 0.05 each and less than or equal to 0.15 in total, balance aluminium. A process of manufacturing the product includes the steps of continuous casting an aluminium alloy melt of the above composition, cold rolling the cast product without an interanneal step to a gauge below 200 μm and final annealing the cold rolled product. The product may be a deep drawn container.
Patent DK-1952466-T3 (DK)
Inventor: VON ALVENSLEBEN FERDINAND
IPC: H01M4/04
Filed: 2006-11-24
Granted: 2009-12-14
Abstract: Closing device has a base member (5) with projections (3) which are pretensioned opposite the walls of the tubes and when the device is correctly positioned engage at the ends in the tubes. The closing device is fixed with the pretensioned projections and at least two adjoining projections have detent catches (13,14) which clamp with the walls. The projections can have a ring-shaped wall arranged on the base member whereby its side remote from the base member is closed by a head region (8) whose external contour corresponds to the internal cross section of the relevant tube.
Patent DK-1970084-T3 (DK)
Inventor: LINIGER JUERG
IPC: A61M5/158
Filed: 2007-03-14
Granted: 2010-11-22
Abstract: The insertion device has a contact area (2) for putting insertion device on an application place at the body of the patient with the application of an insertion head (12). The retaining units (6) are provided for temporary holding applied insertion head at the insertion device. The operating units (8,9) are provided for producing an insertion movement of the insertion head to the contact area in longitudinal direction of a infusion cannula (11) or puncture point of the application causing insertion head. An independent claim is also included for a method for the application of an insertion head, particularly as infusion set.
Patent DK-2137291-T3 (DK)
Inventor: HERTEL KATJA
IPC: C12C7/20
Filed: 2008-04-11
Granted: 2012-07-23
Abstract: The invention provides a method for wort boiling within the course of a beer brewing process, wherein the wort (W) to be boiled is supplied to a brew kettle (2) discontinuously in batches, each batch (C) of the wort (W) supplied to the brew kettle (2) is removed from the brew kettle (2) during the circulation process and is conducted over a rectification column (10), hot steam (D) or hot inert gas is supplied to the rectification column (10), the wort (W) is rectified by the hot steam (D) or by the hot inert gas in the counter flow, and the rectified wort (W) is returned from the rectification column (10) into the brew kettle (2). The invention further provides a device (1) suitable for carrying out the method.
Patent DK-2217105-T3 (DK)
Inventor: BARBAZA MARIE-FRANCE
IPC: A45D24/22
Filed: 2008-11-27
Granted: 2012-07-02
Abstract: The invention relates to an applicator for a device for packaging and dispensing a product, in particular a hair-care product, that comprises a dispensing head (18) provided with at least two application end pieces (34, 36) each including at least one product dispensing opening (52, 54) having a longitudinal axis (Y-Y'), and means (56, 58) axially protruding relative to said dispensing openings (52, 54), said means being capable of bearing against the scalp in order to guide the applicator and to massage the scalp during the movement of said applicator.
Patent DK-2096110-T3 (DK)
Inventor: AKHAVAN-TAFTI HASHEM
IPC: C07F9/6558
Filed: 2002-12-18
Granted: 2011-10-10
Abstract: Novel compounds comprising a C-C double bound substituted at one carbon with two sulphur atom-containing groups are disclosed. The compounds are useful in methods and compositions for generating chemiluminescence rapidly by reaction with a peroxidase enzyme and a peroxide. The chemiluminescence thus produced can be used as a detactable signal in assays for peroxidase enzymes or peroxide-producing enzymes and in assays employing enzyme-labeled specific binding pairs.
Patent DK-2280070-T3 (DK)
Inventor: KAY MARK
IPC: C12N15/11
Filed: 2002-07-19
Granted: 2015-08-24
Abstract: Methods and compositions are provided for modulating, e.g., reducing, coding sequence expression in mammals. In the subject methods, an effective amount of an RNAi agent, e.g., an interfering ribonucleic acid (such as an siRNA or shRNA) or a transcription template thereof, e.g., a DNA encoding an shRNA, is administered to a non-embryonic mammal, e.g., via a hydrodynamic administration protocol. Also provided are RNAi agent pharmaceutical preparations for use in the subject methods. The subject methods and compositions find use in a variety of different applications, including academic and therapeutic applications.
Patent DK-0407909-T3 (DK)
Inventor: SCHWALL HORST DR DIPL-CHEM
IPC: C07C69/716
Filed: 1990-07-06
Granted: 1995-01-16
Abstract: In a process for obtaining lower alkyl esters of R-(+)-3-oxocycloalkane carboxylic acids, the corresponding racemate undergoes hydrolysis at a pH between 7 and 8 in order to hydrolyse the unwanted enantiomer. The ester of interest can then be isolated from the reaction medium.